프로그램

일시 : 2021년 11월 13일(토) *실시간 온라인 컨퍼런스

  Morning Scientific Symposium 좌장: 김상위 (서울아산병원)
08:50~09:30 More TOMORROWs into REALITY for Metastatic NSCLC Patients in the First-line 안희경 (가천대길병원)
  Plenary Session  
  Lung Cancer Care Updated from WCLC 2021 좌장: 장윤수 (강남세브란스병원)
09:30~09:50 Reducing Disparity and Stigma in Lung Cancer Care 정재욱 (충남대병원)
09:50~10:10 Difference of Lung Cancer Screening in the World 구진모 (서울대병원)
10:10~10:30 Targeted Therapy for Exon 20 and MET Mutation 홍숙희 (서울성모병원)
  Immuno-biology and Novel Immunotherapeutics 좌장: 안진석 (삼성서울병원)
10:30~10:50 IO in the Surgical Resectable Lung Cancer 이창영 (신촌세브란스병원)
10:50~11:10 Immunotherapy Resistance in Lung Cancer 김효진 (분당서울대병원)
11:10~11:30 Novel Immunotherapeutic Approach from WCLC 2021 윤신교 (서울아산병원)
11:30~11:40 Q&A 
  Scientific Symposium   좌장: 강진형 (서울성모병원)
11:40~12:30 Push the Boundaries of Science for EGFRm NSCLC : Osimertinib across Advanced and Early Stage EGFRm NSCLC 김혜련 (신촌세브란스병원)
12:30~13:00 Break
  Room A Room B Room C
Parallel Session Multidisciplinary: Oligometastasis

좌장: 박인규 (서울대병원)

  Imaging and Screening

좌장: 유진영 (충북대병원)

13:00~13:20
Definition and Surgical Treatment in Oligometastatic Disease

이진구 (신촌세브란스병원)

  13:00~13:25
Lung Cancer Screening Updates: Nodule Management Protocol and Outcome

황의진 (서울대병원)

13:20~13:40
Radiation Therapy in Oligometastatic Disease

윤홍인 (신촌세브란스병원)

13:25~13:50
Double-sidedness of Lung Cancer Screening: False Positives and Delayed Diagnosis

정원기 (전남대병원)

13:40~14:00
Systemic Therapy Influenced Trials in Oligometastatic Disease

박세훈 (삼성서울병원)

13:50~14:15
Nodules Attached to the Costal Pleura at Low-dose CT Screening

박소현 (강원대병원)

14:00~14:20 Discussion 14:15~14:20 Discussion
Advanced NSCLC

좌장: 조은경 (가천대길병원)

Pulmonology

좌장: 김승준 (서울성모병원)

Pathology & Biomarker Discovery

좌장: 하승연 (가천대길병원)

14:20~14:50
Expanding Immunotherapy

김일환 (해운대백병원)

14:20~14:40
TNM Staging

박동원 (한양대병원)

14:20~14:40
The Role of Biomarkers for Immunotherapy and Targeted Therapy in the Adjuvant and Neoadjuvant Setting

박혜성 (이대서울병원)

14:40~15:00
Screening and Early Detection

김연욱 (분당서울대병원)

14:40~15:00
The Role of Immune Microenvironment Subtypes for Immunotherapy

김태정 (여의도성모병원)

14:50~15:20
Novel Combinations of Osimertinib

홍민희 (신촌세브란스병원)

15:00~15:20
Liquid Biopsy

김희정 (건국대병원)

15:00~15:20
Genomic Alterations in NSCLC

심효섭 (신촌세브란스병원)

15:20~15:30Discussion   15:20~15:30 Discussion 15:20~15:30 Discussion
15:30~16:00 Break
Thoracic Malignancies

좌장: 김주항 (분당차병원)

Thoracic Surgical Oncology

좌장: 김현구 (고려대구로병원)

Arising Issues in Radiation Oncology

좌장: 김수산 (서울아산병원)

16:00~16:20
Small Cell Lung Cancer

이경원 (경상대병원)

16:00~16:20
Novel Therapy for Resectable Stage IIIA Non-small Lung Cancer

황유화 (분당서울대병원)

16:00~16:20
Radiotherapy for Early Stage NSCLC

임채홍 (고려대안산병원)

16:20-16:40
Thymic Malignacy/Mesothelioma

이서영 (강남세브란스병원)

16:20~16:40
The Role of Surgery in Locally Advanced Stage III Non-small Cell Lung Cancer

신수민 (삼성서울병원)

16:20~16:40
Radiotherapy for Early Locally Advanced NSCLC

김경환 (신촌세브란스병원)

16:40-17:00
Clinical Impact of Liquid Biopsy for NSCLC Patients

안병철 (국립암센터)

16:40~17:00
Neoadjuvant Chemotherapy Plus Immunotherapy for Stage IIIA Non-small Cell Lung Cancer

박샘이나 (서울대병원)

16:40~17:00
Radiotherapy for SCLC and Other Thoracic Tumors (Mesothelioma / Thymoma)

곽유강 (인천성모병원)

17:00~17:10 Discussion 17:00~17:10 Discussion 17:00~17:10 Discussion
Copyright (c) 2013 by Korean Society of Medical Oncology. All rights reserved.
03186 서울특별시 종로구 새문안로 92 (신문로1가 163) 광화문오피시아빌딩 2220호 TEL : 02-735-2857 FAX : 02-735-2856 E-mail : meetings@ksmo.or.kr